By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm IncellDx today said it has closed a $3 million Series A financing.

IncellDx did not disclose the names of the investors in the round.

Proceeds will be used to further commercialize the company's products and initiate the US clinical trial for its test for human papillomavirus, HPV OncoTect, a CE-marked E6, E7 mRNA test, IncellDx said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.